These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 32740999)
1. Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration. Landa J; Gaig C; Plagumà J; Saiz A; Antonell A; Sanchez-Valle R; Dalmau J; Graus F; Sabater L Ann Neurol; 2020 Nov; 88(5):1023-1027. PubMed ID: 32740999 [TBL] [Abstract][Full Text] [Related]
2. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. Sabater L; Planagumà J; Dalmau J; Graus F J Neuroinflammation; 2016 Sep; 13(1):226. PubMed ID: 27586161 [TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human Neurons. Ryding M; Gamre M; Nissen MS; Nilsson AC; Okarmus J; Poulsen AAE; Meyer M; Blaabjerg M Cells; 2021 Apr; 10(4):. PubMed ID: 33917676 [TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature. Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376 [TBL] [Abstract][Full Text] [Related]
13. IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease. Morales-Briceño H; Cruse B; Fois AF; Lin MW; Jiang J; Banerjee D; Grunstein R; Varikatt W; Rodriguez M; Shepherd C; Fung VSC Neurology; 2018 Jun; 90(24):1113-1115. PubMed ID: 29769372 [No Abstract] [Full Text] [Related]
14. Teaching Video NeuroImages: Anti-IgLON5 Disease: A Long-Course Presentation With a Response to Immunotherapy. Villacieros-Álvarez J; Ordás CM; Torres-Gaona G; Díez-Barrio A; Prieto-Jurczynska C; Gaig C Neurology; 2021 Jun; 96(23):e2901-e2902. PubMed ID: 33361260 [No Abstract] [Full Text] [Related]
15. Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice. Alvente S; Matteoli G; Molina-Porcel L; Landa J; Alba M; Bastianini S; Berteotti C; Graus F; Lo Martire V; Sabater L; Zoccoli G; Silvani A Cells; 2022 Mar; 11(6):. PubMed ID: 35326477 [TBL] [Abstract][Full Text] [Related]
18. Anti-neurofilament antibodies and neurodegeneration: Markers and generators. Zmira O; Halpern AI; Drori T J Neuroimmunol; 2020 Jul; 344():577248. PubMed ID: 32344161 [TBL] [Abstract][Full Text] [Related]
19. Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy. Erro ME; Sabater L; Martínez L; Herrera M; Ostolaza A; García de Gurtubay I; Tuñón T; Graus F; Gelpi E Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31826985 [TBL] [Abstract][Full Text] [Related]